All NewsBio/Pharma News
All PublicationsPharmTechPharmTech Europe
MarketplaceICH Q9 Revision: A Comprehensive Resource on Quality Risk ManagementPeer-Reviewed ResearchPharmTech ProductsPharma InsightsSponsored PodcastsSponsored VideosSponsored eBooksWhitepapers
Webcasts
All VideosAsk the ExpertBehind The HeadlinesBuy, Sell, HoldDrug Digest VideosDrug Solutions PodcastPeer ExchangeSexy ScienceTech Talk
Conference CoverageConference ListingEvents
Subscribe
AnalyticsAnalyticsAnalytics
Data and Artificial Intelligence
Dosage FormsDosage FormsDosage FormsDosage FormsDosage Forms
Drug DevelopmentDrug DevelopmentDrug DevelopmentDrug DevelopmentDrug DevelopmentDrug Development
ManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturing
OutsourcingOutsourcingOutsourcingOutsourcingOutsourcingOutsourcingOutsourcing
Quality SystemsQuality SystemsQuality SystemsQuality Systems
Spotlight -
  • Analytics
  • Dosage Forms
  • Drug Development
  • Manufacturing
  • Outsourcing
  • Quality Systems
IS1
  • Applied Clinical Trials

  • BioPharm International

  • Cannabis Science and Technology

  • Chromatography Online

  • Nutritional Outlook

  • Pharmaceutical Commerce

  • Pharmaceutical Executive

  • Pharm Tech

  • Spectroscopy Online

  • Turbo Machinery Magazine

AnalyticsAnalyticsAnalytics
Data and Artificial Intelligence
Dosage FormsDosage FormsDosage FormsDosage FormsDosage Forms
Drug DevelopmentDrug DevelopmentDrug DevelopmentDrug DevelopmentDrug DevelopmentDrug Development
ManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturingManufacturing
OutsourcingOutsourcingOutsourcingOutsourcingOutsourcingOutsourcingOutsourcing
Quality SystemsQuality SystemsQuality SystemsQuality Systems
IS1
  • Applied Clinical Trials

  • BioPharm International

  • Cannabis Science and Technology

  • Chromatography Online

  • Nutritional Outlook

  • Pharmaceutical Commerce

  • Pharmaceutical Executive

  • Pharm Tech

  • Spectroscopy Online

  • Turbo Machinery Magazine

    • Webcasts
    • Subscribe

Article

Equipment and Processing Report

November 16, 2011

Equipment and Processing Report

Equipment and Processing Report-11-16-2011
Volume0
Issue 0

November 2011 Editor's Picks: Products from Sartorius Stedim Biotech and Thermo Fisher Scientific

Author(s):

Pharmaceutical Technology Editors

PharmTech's monthly newsletter, Equipment and Processing Report, reviews the Editor's Picks for the November 2011 edition from Sartorius Stedim Biotech and Thermo Fisher Scientific.

Sartorius Stedim Biotech
Membrane binds contaminants at high conductivities

The Sartobind STIC PA membrane from Sartorius Stedim Biotech uses free primary-amino ligands at high density to bind contaminants at high conductivities through ion exchange. Unlike traditional quaternary ammonium membranes, the Sartobind STIC PA membrane does not require the cation ion-exchange pools to be diluted to bind the negatively charged contaminants. This characteristic can help users reduce buffer consumption and buffer-tank costs. The Sartobind membrane also removes host-cell proteins, DNA, viruses, and endotoxins at salt conditions as high as 20 mS/cm.

The series of membranes includes six capsule sizes from 0.08 mL to 1.6 L. All of the membranes are suitable for flow-through polishing, and users can maintain a 4-mm bed height to scale up to larger devices. The membrane-adsorber capsules are plug-and-play devices that can be used like filters. Personnel can discard the materials after a single use, thus reducing validation costs.

Thermo Fisher Scientific
Roller bottles help improve yields and scale-up

Thermo Fisher Scientific has introduced its Thermo Scientific Nunc TufRol PS roller bottles for cell-culture production. Nunc TufRol PS roller bottles use polystyrene materials, thus minimizing the effort required to validate cell culture scale-up processes. Designed with indentations at the bottom to facilitate manual and automated handling, TufRol roller bottles are also available with vertical pleats to facilitate emptying and reduce product retention.

TufRol roller bottles were added to the existing Thermo Scientific Nunc InVitro PETG roller-bottle product line. Nunc InVitro PETG roller bottles are molded of polyethylene terephthalate, which is stronger than glass under normal culture applications. These bottles can withstand temperatures as low as –40 °C to accommodate freeze–thaw release protocols. Nunc InVitro roller bottles are available with a poly-D-lysine coating, which is used to promote cell attachment for cell lines that are difficult to grow. In addition, the bottles’ surface area of 1450 cm2 can result in larger product yields, compared with traditional roller bottles.

Articles in this issue

Collapsed Cakes
Sartobind_STIC_picoWEB-748224-1408609823851.jpg
November 2011 Editor's Picks: Products from Sartorius Stedim Biotech and Thermo Fisher Scientific
Pharmaceutical Manufacturers Seek to Eliminate Waste
Is Three Still the Magic Number for Process Validation?

Newsletter

Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.

Subscribe Now!
Related Videos
Dave Miller, PhD, Chief Scientific Officer, AustinPx
Dave Miller, PhD, Chief Scientific Officer, AustinPx
Related Content
Advertisement
Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com
August 19th 2025

Telstar to Showcase Integrated GMP Services at Farmaforum

Susan Haigney
Drug Solutions Podcast: Growth and Advancements in Fill/Finish
August 19th 2025

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Felicity Thomas
White pills on blue background | Image Credit: © neirfy - © neirfy - stock.adobe.com
August 19th 2025

EMA Grants Orphan Designation to Rilzabrutinib for IgG4-Related Disease

Feliza Mirasol
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
August 19th 2025

Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines

Feliza Mirasol
AbbVie’s facility in Silicon Valley, South San Francisco, California, USA - June 7, 2023. AbbVie Inc. is an American pharmaceutical company. | Image Credit: © JHVEPhoto - stock.adobe.com
August 19th 2025

AbbVie to Invest $195 Million in US API Manufacturing

Patrick Lavery
Coronavirus 2019-nCov novel coronavirus concept resposible for asian flu outbreak and coronaviruses influenza as dangerous flu strain cases as a pandemic. The virus is made up of purple pills. | Image Credit: © lunarts_studio - stock.adobe.com
August 19th 2025

BARDA Pulls Plug on Vaxart Oral COVID Vaccine Trial After mRNA Rollback

Patrick Lavery
Related Content
Advertisement
Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com
August 19th 2025

Telstar to Showcase Integrated GMP Services at Farmaforum

Susan Haigney
Drug Solutions Podcast: Growth and Advancements in Fill/Finish
August 19th 2025

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Felicity Thomas
White pills on blue background | Image Credit: © neirfy - © neirfy - stock.adobe.com
August 19th 2025

EMA Grants Orphan Designation to Rilzabrutinib for IgG4-Related Disease

Feliza Mirasol
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
August 19th 2025

Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines

Feliza Mirasol
AbbVie’s facility in Silicon Valley, South San Francisco, California, USA - June 7, 2023. AbbVie Inc. is an American pharmaceutical company. | Image Credit: © JHVEPhoto - stock.adobe.com
August 19th 2025

AbbVie to Invest $195 Million in US API Manufacturing

Patrick Lavery
Coronavirus 2019-nCov novel coronavirus concept resposible for asian flu outbreak and coronaviruses influenza as dangerous flu strain cases as a pandemic. The virus is made up of purple pills. | Image Credit: © lunarts_studio - stock.adobe.com
August 19th 2025

BARDA Pulls Plug on Vaxart Oral COVID Vaccine Trial After mRNA Rollback

Patrick Lavery
About Us
Advertise
Contact Us
Editorial Info
Editorial Advisory Board
Do Not Sell My Personal Information
Privacy Policy
Terms and Conditions
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

© 2025 MJH Life Sciences

All rights reserved.